"Can I still have a glass of wine on Ozempic?" It's one of the most common questions we hear from new patients — and it deserves an honest, practical answer. The short version: alcohol isn't completely off the table, but GLP-1 medications change the way your body responds to it significantly. Here's what you need to know.
The headline: GLP-1 medications are not contraindicated with alcohol, but they slow gastric emptying — meaning you will likely feel the effects of alcohol sooner and more intensely than you expect. Many patients also find they naturally want far less alcohol on Ozempic or Mounjaro. Heavy drinking will significantly undermine your weight loss results.
Ozempic (semaglutide), Mounjaro (tirzepatide), and Wegovy all slow gastric emptying — the rate at which your stomach empties food and liquid into the small intestine. With alcohol, this has two important effects:
The practical consequence: your "safe" baseline amount of alcohol is lower on these medications. Start cautiously when you first begin treatment, even if you've been a habitual drinker.
One of the most clinically interesting — and unexpected — effects many patients report is a dramatic reduction in alcohol cravings. This isn't a coincidence.
GLP-1 receptors exist not only in the gut but in the brain's reward and pleasure centres, including the ventral tegmental area (VTA) and nucleus accumbens — the same pathways involved in addiction and cravings. Emerging research suggests semaglutide may reduce dopamine-driven cravings for alcohol similarly to how it reduces food cravings.
Several clinical trials are currently investigating semaglutide specifically as a treatment for alcohol use disorder. Early results are promising. For many patients, the reduction in alcohol desire is unsolicited — they simply find they no longer want their usual drinks without consciously trying to cut back.
If this happens to you: This is a beneficial effect. Don't fight it. Many patients who drank regularly before GLP-1 therapy find they naturally gravitate toward 1–2 drinks at social occasions rather than their prior amount — without willpower or effort.
A glass of wine at dinner, a beer at a braai, a drink at a social occasion — generally manageable for most patients. Eat before drinking. Be aware your tolerance is lower. Avoid this on days you're experiencing significant GI side effects (nausea, slow digestion).
This will meaningfully slow your progress. Alcohol is calorie-dense (7 kcal/g — almost as much as fat) and is often accompanied by calorie-dense mixers and food choices. At this frequency, it will significantly impair the results you get from GLP-1 therapy.
Strongly discouraged. Risk of severe nausea, vomiting, and hypoglycaemia (if on additional diabetes medications). Heavy alcohol can also trigger pancreatitis — a condition GLP-1 medications already carry a small theoretical risk for. Pancreatitis is serious and potentially life-threatening. Any sudden, severe abdominal pain while on GLP-1 therapy warrants immediate emergency assessment.
| Effect of Alcohol | Impact on GLP-1 Weight Loss |
|---|---|
| High calorie density (7 kcal/g) | Offsets calorie deficit — 2 glasses of wine = ~300 kcal |
| Disrupts REM and deep sleep | Raises cortisol, increases hunger next day, impairs fat metabolism |
| Lowers inhibitions around food | Late-night eating, poor choices after drinking |
| Triggers hunger ("the munchies") | Alcohol activates appetite-stimulating neurons |
| Raises cortisol (stress hormone) | Promotes abdominal fat retention |
| Impairs liver function | Liver processes alcohol before fat — fat burning pauses |
If you're on Ozempic for type 2 diabetes AND also taking insulin, sulphonylureas (like glibenclamide, gliclazide), or other hypoglycaemic agents: alcohol significantly increases your risk of low blood sugar (hypoglycaemia). Always eat before and during drinking, monitor your glucose levels, and carry fast-acting sugar. Tell whoever you're with that you're on diabetes medication. Never drink on an empty stomach.
Stop drinking and seek immediate medical care if you develop sudden, severe upper abdominal pain while on any GLP-1 medication. Heavy alcohol use is a known trigger for pancreatitis — and GLP-1 medications carry a theoretical (low but real) increase in pancreatitis risk in susceptible individuals. The combination requires urgent evaluation. Do not wait to see if it passes.
Patients who consume alcohol heavily (4+ drinks 3+ times per week) routinely underperform compared to those who don't. The STEP trials that established semaglutide's 15% weight loss benchmark enrolled patients who followed a hypocaloric diet — alcohol was limited or absent. Real-world results for heavy drinkers on GLP-1 therapy are substantially lower.
For optimal results: think of GLP-1 therapy as a window of significantly reduced alcohol cravings. Use it. Many patients who previously drank regularly find this the easiest time in their lives to naturally cut back — without white-knuckle willpower.
Your doctor will personalise guidance for diet, alcohol, and exercise at your consultation. Start your journey with an online assessment.
Book Consultation — R700